EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention

Masood Khan, Nadir Khan, Muhammad Masoom, Sohaib Khan, Shabbir Ahmad, Anwar Hussain

Aposta: Revista de Ciencias Sociales · 11.05.2026 · 24 (112) · e871

DOI: 10.23900/ra.v24i112.871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aposta: Revista de Ciencias Sociales, online erschienen am 11.05.2026. Verfasst von Masood Khan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

No reflow phenomenon (NRP) is a rare, but serious, complication of percutaneous coronary intervention (PCI), in which the myocardial perfusion does not improve despite successful epicardial coronary artery recanalization. Local intracoronary drug delivery is an area of increasing interest as a potential way to control NRP.

Objective

The efficacy and safety of intracoronary infusions of vasodilators and antiplatelet drugs in the distal coronary bed for NRP during PCI has been studied.

Methods

This prospective observational study was conducted in the Department of Cardiology of Armed Forces Institute of Cardiology (AFIC) Rawalpindi feom November 2025 to March 2026. 150 Patients who developed NRP during PCI were included. Intracoronary vasodilators and antiplatelet agents were delivered locally into the distal coronary bed. Treatment efficacy was assessed by improvement in TIMI flow, myocardial blush grade, and ST-segment resolution. Safety was evaluated by recording drug-related adverse events, including hypotension, bradycardia, arrhythmias, and allergic reactions.

Results

TIMI III flow was obtained in 78%, myocardial blush grade 2–3 in 72% and ST-segment resolution ≥50% in 75%. There were no significant adverse events related to drugs. In 5% of patients, minor hypotension was observed.

Conclusion

Intra-coronary drug delivery in the distal coronary bed is a safe and effective approach to reverse NRP during PCI, providing better myocardial perfusion without substantial complications.

Zitieren

APA

Khan, M., Khan, N., Masoom, M., Khan, S., Ahmad, S., & Hussain, A. (2026). Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention. Aposta: Revista de Ciencias Sociales, 24(112), e871. https://doi.org/10.23900/ra.v24i112.871

Vancouver

Khan M, Khan N, Masoom M, Khan S, Ahmad S, Hussain A. Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention. Aposta: Revista de Ciencias Sociales. 2026;24(112):e871. doi:10.23900/ra.v24i112.871

BibTeX
@article{Khan2026,
  author = {Khan, Masood and Khan, Nadir and Masoom, Muhammad and Khan, Sohaib and Ahmad, Shabbir and Hussain, Anwar},
  title = {Efficacy and safety of local intracoronary drug delivery in the distal coronary bed as treatment of no-reflow phenomenon during percutaneous coronary intervention},
  journal = {Aposta: Revista de Ciencias Sociales},
  year = {2026},
  volume = {24},
  number = {112},
  pages = {e871},
  doi = {10.23900/ra.v24i112.871}
}
Kostenlos starten →